Skip to main content
Log in

Clinical applications of assessments of myocardial substrate utilization with positron emission tomography

  • Invited Paper
  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Summary

Positron emission tomography (PET) permits sequential, noninvasive assessment of myocardial perfusion and metabolism. Based on the pattern of substrate use, clinical studies have utilized PET to define the location and extent of myocardial infarction, to identify areas of jeopardized but viable myocardium, and to assess the metabolic response of the myocardium to pharmacological therapy as well as to interventions such as coronary thrombolysis and coronary artery bypass surgery. The ability to noninvasively assess specific metabolic pathways should facilitate our understanding of normal myocardial metabolism, its perturbations with cardiac disease, and thereby improve the diagnosis and treatment of the biochemical processes underlying cardiac dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bing RJ: Cardiac metabolism. Physiol Rev 45: 171–213, 1965

    Google Scholar 

  2. Neely JR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 36: 413–459, 1974

    Google Scholar 

  3. Liedtke AJ: Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 23: 321–336, 1981

    Google Scholar 

  4. Bergmann SR, Fox KAA, Geltman EM, Sobel BE: Positron emission tomography of the heart. Prog Cardiovasc Dis 28: 165–194, 1985

    Google Scholar 

  5. Fox KAA, Abendschein DR, Ambos HD, Sobel BE, Bergmann SR: Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Circ Res 57: 232–243, 1985

    Google Scholar 

  6. Rosamond TL, Abendschein DR, Sobel BE, Bergmann SR, Fox KAA: Metabolic fate of radiolabeled palmitate in ischemic canine myocardium: implications for positron emission tomography. J Nucl Med 28: 1322–1329, 1987

    Google Scholar 

  7. Weiss ES, Hoffman EJ, Phelps ME, Welch MJ, Henry PD, Ter-Pogossian MM, Sobel BE: External detection and visualization of myocardial ischemia with 11C-substrates in vitro and in vivo. Circ Res 39: 24–32, 1976

    Google Scholar 

  8. Bergmann SR, Clark RE, Sobel BE: An improved isolated heart preparation for external assessment of myocardial metabolism. Am J Physiol: Heart Circ Physiol 236: H644-H651, 1979

    Google Scholar 

  9. Goldstein RA, Klein MS, Welch MJ, Sobel BE: External assessment of myocardial metabolism with C-11 palmitate in vivo. J Nucl Med 21: 342–348, 1980

    Google Scholar 

  10. Lerch RA, Ambos HD, Bergmann SR, Welch MJ, Ter-Pogossian MM, Sobel BE: Localization of viable, ischemic myocardium by positron-emission tomography with 11C-palmitate. Circulation 64: 689–699, 1981

    Google Scholar 

  11. Lerch RA, Bergmann SR, Ambos HD, Welch MJ, Ter-Pogossian MM, Sobel BE: Effect of flow-independent reduction of metabolism on regional myocardial clearance of 11C-palmitate. Circulation 65: 731–738, 1982

    Google Scholar 

  12. Schon HR, Schelbert HR, Robinson G, Najafi A, Huang S-C, Hansen H, Barrio J, Kuhl DE, Phelps ME: C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C-11 palmitic acid in normal myocardium. Am Heart J 103: 532–547, 1982

    Google Scholar 

  13. Schon HR, Schelbert HR, Najafi A, Hansen H, Huang H, Barrio J, Phelps ME: C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. II. Kinetics of C-11 palmitic acid in acutely ischemic myocardium. Am Heart J 103: 548–561, 1982

    Google Scholar 

  14. Schelbert HR, Henze E, Schon HR, Keen R, Hansen H, Selin C, Huang S-C, Barrio JR, Phelps ME: C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Am Heart J 105: 492–504, 1983

    Google Scholar 

  15. Schelbert HR, Henze E, Sochor H, Grossman RG, Huang S-C, Barrio JR, Schwaiger M, Phelps ME: Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction. Am Heart J 111: 1055–1064, 1986

    Google Scholar 

  16. Weiss ES, Ahmed SA, Welch MJ, Williamson JR, Ter-Pogossian MM, Sobel BE: Quantification of infarction in cross sections of canine myocardium in vivo with positron emission transaxial tomography and 11C-palmitate. Circulation 55: 66–73, 1977

    Google Scholar 

  17. Sobel BE, Weiss ES, Welch MJ, Siegel BA, Ter-Pogossian MM: Detection of remote myocardial infarction in patients with positron emission transaxial tomography and intravenous 11C-palmitate. Circulation 55: 853–857, 1977

    Google Scholar 

  18. Ter-Pogossian MM, Klein MS, Markham J, Roberts R, Sobel BE: Regional assessment of myocardial metabolic integrity in vivo by positron-emission tomography with 11C-labeled palmitate. Circulation 61: 242–255, 1980

    Google Scholar 

  19. Geltman EM, Biello D, Welch MJ, Ter-Pogossian MM, Roberts R, Sobel BE: Characterization of nontransmural myocardial infarction by positron-emission tomography. Circulation 65: 747–755, 1982

    Google Scholar 

  20. Billadello JJ, Smith JL, Ludbrook PA, Tiefenbrunn AJ, Jaffe AS, Sobel BE, Geltman EM: Implications of ‘reciprocal’ ST segment depression associated with acute myocardial infarction identified by positron tomography. J Am Coll Cardiol 2: 616–624, 1983

    Google Scholar 

  21. Bergmann SR, Lerch RA, Fox KAA, Ludbrook PA, Welch MJ, Ter-Pogossian MM, Sobel BE: Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med 73: 573–581, 1982

    Google Scholar 

  22. Jaffe AS, Biello DR, Sobel BE, Geltman EM: Enhancement of metabolism of jeopardized myocardium by nifedipine. Int'l J Cardiol 15: 77–89, 1987

    Google Scholar 

  23. Sobel BE, Geltman EM, Tiefenbrunn AJ, Jaffe AS, Spadaro JJ, Ter-Pogossian MM, Collen D, Ludbrook PA: Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase. Circulation 69: 983–990, 1984

    Google Scholar 

  24. Knabb RM, Rosamond TL, Fox KAA, Sobel BE, Bergmann SR: Enhancement of salvage of reperfused ischemic myocardium by diltiazem. J Am Coll Cardiol 8: 861–871, 1986

    Google Scholar 

  25. Knabb RM, Bergmann SR, Fox KAA, Sobel BE: The temporal pattern of recovery of myocardial perfusion and metabolism delineated by positron emission tomography after coronary thrombolysis. J Nucl Med 28: 1563–1570, 1987

    Google Scholar 

  26. Schwaiger M, Schelbert HR, Ellison D, Hansen H, Yeatman L, Vinten-Johansen J, Selin C, Barrio J, Phelps ME: Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 6: 336–347, 1985

    CAS  PubMed  Google Scholar 

  27. Grover-McKay M, Schelbert HR, Schwaiger M, Sochor H, Guzy PM, Krivokapich J, Child JS, Phelps ME: Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis. Circulation 74: 281–292, 1986

    Google Scholar 

  28. Geltman EM, Smith JL, Beecher D, Ludbrook PA, Ter-Pogossian MM, Sobel BE: Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography. Am J Med 74: 773–785, 1983

    Google Scholar 

  29. Eisenberg JD, Sobel BE, Geltman EM: Differentiation of ischemic from nonischemic cardiomyopathy with positron emission tomography. Am J Cardiol 59: 1410–1414, 1987

    Google Scholar 

  30. Sochor H, Schelbert HR, Schwaiger M, Henze E, Phelps ME: Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy. Eur J Nucl Med 12: S66-S69, 1986

    Google Scholar 

  31. Livni E, Elmaleh DR, Levy S, Brownell GL, Strauss WH: Beta-methyl[1-11C]heptadecanoic acid: a new myocardial metabolic tracer for positron emission tomography. J Nucl Med 23: 169–175, 1982

    Google Scholar 

  32. Abendschein DR, Fox KAA, Ambos HD, Sobel BE, Bergmann SR: Metabolism of beta-methyl[1-11C]heptadecanoic acid in canine myocardium. Nucl Med Biol 14: 579–585, 1987

    Google Scholar 

  33. Ratib O, Phelps ME, Huang S-C, Henze E, Selin CE, Schelbert HR: Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 23: 577–586, 1982

    Google Scholar 

  34. Marshall RC, Huang S-C, Nash WW, Phelps ME: Assessment of the [18F]fluorodeoxyglucose kinetic model in calculations of myocardial glucose metabolism during ischemia. J Nucl Med 24: 1060–1064, 1983

    Google Scholar 

  35. Krivokapich J, Huang S-C, Selin CE, Phelps ME: Fluorodeoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart. Am J Physiol: Heart Circ Physiol 252: H777-H787, 1987

    Google Scholar 

  36. Marshall RC, Tillisch JH, Phelps ME, Huang S-C, Carson R, Henze E, Schelbert HR: Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 67: 766–786, 1983

    Google Scholar 

  37. Schwaiger M, Brunken R, Grover-McKay M, Krivokapich J, Child J, Tillish JH, Phelps ME, Schelbert HR: Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 8: 800–808, 1986

    Google Scholar 

  38. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H: Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314: 884–888, 1986

    Google Scholar 

  39. Schwaiger M, Brunken RC, Krivokapich J, Child JS, Tillisch JH, Phelps ME, Schelbert HR: Beneficial effect of residual anterograde flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction. Eur Heart J 8: 981–988, 1987

    Google Scholar 

  40. Camici P, Araujo LL Spinks T, Lammertsma AA, Kaski JC, Shea MJ, Selwyn AP, Jones T, Maseri A: Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation 74: 81–88, 1986

    Google Scholar 

  41. Brunken R, Tillisch J, Schwaiger M, Child JS, Marshall R, Mandelkern M, Phelps ME, Schelbert HR: Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic O wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 73: 951–963, 1986

    Google Scholar 

  42. Perloff JK, Henze E, Schelbert HR: Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. Circulation 69: 33–42, 1984

    Google Scholar 

  43. Goldstein RA, Klein MS, Sobel BE: Detection of myocardial ischemia before infarction, based on accumulation of labeled pyruvate. J Nucl Med 21: 1101–1104, 1980

    Google Scholar 

  44. Fox KAA, Ambos HD, Bergmann SR, Sobel BE: External measurement of myocardial oxygen utilization with 0–15 labeled oxygen. Circulation 68: III-82, 1983 (abstract)

    Google Scholar 

  45. Brown M, Marshall DR, Sobel BE, Bergmann SR: Delineation of myocardial oxygen utilization with carbon-11labeled acetate. Circulation 76: 687–696, 1987

    Google Scholar 

  46. Brown MA, Myears DW, Bergmann SR: Noninvasive assessment of canine myocardial oxidative metabolism with 11C-acetate and positron emission tomography. J Am Coll Cardiol 12: 1054–1063, 1988

    Google Scholar 

  47. Brown MA, Myears DW, Bergmann SR: Validity of estimates of myocardial oxidative metabolism with carbon-11-acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 30: 187–193, 1989

    Google Scholar 

  48. Brown MA, Walsh MN, Weinheimer CJ, Geltman EM, Sobel BE, Bergmann SR: Assessment of regional oxidative metabolism by positron tomography with C-11-acetate in patients with myocardial infarction. J Nucl Med 29: 818, 1988 (Abstr)

    Google Scholar 

  49. Walsh MN, Brown MA, Henes CG, Weinheimer CJ, Geltman EM, Sobel BE, Bergmann SR: Estimation of regional myocardial oxidative metabolism by positron emission to mography with carbon-11-acetate in patients. Circulation 78: II-599, 1988 (Abstr)

    Google Scholar 

  50. Brown MA, Nohara R, Vered Z, Perez JE, Bergmann SR: The dependence of recovery of stunned myocardium on restoration of oxidative metabolism. Circulation 78: II-467 1988 (Abstr)

    Google Scholar 

  51. Gelbard AS, Benua RS, Reiman RE, McDonald JM, Vomero JJ, Laughlin JS: Imaging of the human heart after administration of L-(N-13)glutamate. J Nucl Med 21: 988–991, 1980

    Google Scholar 

  52. Henze E, Schelbert HR, Barrio JR, Egbert JE, Hansen HW, MacDonald NS, Phelps ME: Evaluation of myocardial metabolism with N-13- and C-11-labeled amino acids and positron computed tomography. J Nucl Med 23: 671–681, 1982

    Google Scholar 

  53. Zimmerman R, Tillmanns H, Knapp WH, Helus F, Georgi P, Rauch B, Neumann F-J, Girgensohn S, Maier-Borst W, Kubler W: Regional myocardial nitrogen-13 glutamate uptake in patients with coronary artery disease: inverse poststress relation to thallium-201 uptake in ischemia. J Am Coll Cardiol 11: 549–556, 1988

    Google Scholar 

  54. Shelton ME, Dence CS, Hwang D-R, Welch MJ, Bergmann SR: Myocardial kinetics of fluorine-18 misonidazole: A marker of hypoxic myocardium. J Nucl Med 30: 351–358, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bergmann, S.R. Clinical applications of assessments of myocardial substrate utilization with positron emission tomography. Mol Cell Biochem 88, 201–209 (1989). https://doi.org/10.1007/BF00223445

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00223445

Key words

Navigation